|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.2500 - 1.2500|
|52 Week Range||0.3500 - 1.6000|
|Beta (5Y Monthly)||1.32|
|PE Ratio (TTM)||1,250.00|
|Earnings Date||Oct 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.70|
Trxade Chairman and CEO Suren Ajjarapu joins NNW’s Stuart Smith to discuss the most recent happenings within the integrated pharmaceutical services company, which offers a unique combination of a web-based purchasing platform for transactions between independent pharmacists and drug distributors, a mail order pharmacy, warehouse, Telemedicine Platform and drug delivery service. During the interview, Ajjarapu noted that for the last seven quarters, Trxade has consistently been profitable. Ajjarapu also discussed the Company’s acquisition of the Bonham Health assets in late October 2019 and noted that Trxade serves indirectly 12 million to 15 million patients through the 11,500 registered independent pharmacies on their B2B supply chain platform.
LOS ANGELES, CA / ACCESSWIRE / December 3, 2019 / Trxade Group, Inc. (OTCQB: TRXD ) ("Trxade" or the "Company"), an integrated pharma supply chain and care platform, today announced ...
The Bonum Health Hub plans to provide the technology and capabilities to provide care for those patients that otherwise would not be able to afford primary or collaborative care. With the first placements being in Benzer Pharmacy, their “People First” philosophy ensures that patients being seen in the Bonum Health Hub will receive the best care possible throughout the entirety of their experience.
Trxade, through Bonum, extends its reach into independent pharmacies in both rural and urban communities that will have a “value add” to compete with the capabilities of the national chains. The Health Hubs will begin rolling out in quarter one of 2020. Bonum Health has enlisted the experienced manufacturing of Uniweb, a company specializing in the creation and structure of modular rooms.
TAMPA, FL / ACCESSWIRE / November 7, 2019 / Trxade Group, Inc. (OTCQB:TRXD) ("Trxade" or the "Company"), an integrated pharma supply chain and care platform, announced today its new wholly owned subsidiary Bonum Health, a leading contributor to the evolution of telehealth medicine. Bonum Health is introducing a revolutionary online healthcare portal that allows users to tap into the clinical expertise of board-certified physicians for a low monthly fee. "Through Bonum Health, we are also able to offer immediate care access through our aggressively low per-consult pricing for primary care, dermatology, and behavioral health consultations.
Revenue Growth of 173% to $2.311 Million Operating Income Growth of 94% to $177,853 7 th straight quarter of positive operating income Shareholder Equity increased to $3.89mil TAMPA, FL / ACCESSWIRE / ...
TAMPA, FL / ACCESSWIRE / October 29, 2019 / Trxade Group, Inc. (OTCQB:TRXD) ("Trxade" or the "Company"), an integrated pharma supply chain and care platform, announced today the acquisition of certain assets of Bonum Health, a comprehensive telemedicine and telehealth platform (www.bonumhealth.com). Additionally, we plan for independent pharmacies to have onsite Bonum health kiosks with clinical services which will allow them to compete with national retail chain pharmacies on pricing, service offerings and patient satisfaction. Bonum Health is an important strategic advancement for Trxade in its mission to disrupt the ineffective and inefficient pharma and consumer care value chain.
TAMPA, FL / ACCESSWIRE / October 22, 2019 / Trxade Group, Inc. (OTCQB:TRXD) ("Trxade" or the "Company"), an integrated pharmaceutical supply chain and care platform, today announced it has elected Gary Augusta, to its Board of Directors. Mr. Augusta has a background as a board member in public company healthcare and technology, as part of his 30 years of experience in finance, healthcare, engineering, technology and other innovative sectors, including leadership roles in mergers and acquisitions, capital markets and investments, corporate development, strategic growth and partnership development. From 2012-2018, Mr. Augusta served as a Board Director, including Executive Chairman (for four years), of Apollo Medical Holdings, Inc. (AMEH).
Faris Sleem, editor of The Bowser Report, is a leading specialist in low-priced, micro-cap stocks; indeed, his latest featured recommendation had 2018 revenues of just $3.8 million.
Revenue Growth of 129% to $1.9 MillionOperating Income Growth of 322% to $132,7051st Half 2019 EPS of $0.01 TAMPA, FL, July 29, 2019 -- Trxade Group, Inc. (OTCQB: TRXD), an.
Trxade Group, Inc. (TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacies and drug manufacturers, MSO with a specialty pharmacy, and a warehouse and drug delivery service for consumers. Trxade is pleased to announce that the registration statement on Form S-1 (the "S-1 Registration Statement") previously filed with the Securities and Exchange Commission (the "SEC") was declared effective by the SEC today, July 2nd, 2019. This S-1 Registration Statement covers the resale from time to time by the selling shareholders identified in the S-1 Registration Statement for up to 31,949,712 shares of our common stock.
Trxade Group, Inc. (TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacists and drug manufacturers, MSO with a Specialty pharmacy. Trxade has warehouse and drug delivery services for consumers further advanced capabilities today by announcing that company’s subsidiary Community Specialty Pharmacy (https://www.comsprx.com ) has secured its certification with LegitScript.
First Quarter Highlights: Company achieves record revenues of $1.512 million in quarter ending March 31, 2019 an increase from $852,923 in quarter ending March 31, 2018 Operating Income Increased to $171,759 ...
NEW YORK, April 23, 2019 -- via NetworkWire - Trxade Group Inc. (OTCQB: TRXD), an integrated drug purchasing and delivery platform that enables trade among healthcare buyers.
TAMPA, Fla., March 26, 2019 -- Trxade Group, Inc., (OTCQB: TRXD) is an integrated drug purchasing and delivery solutions company with a market platform that enables trade among.
Expected to Drive Revenue Growth in 2019 TAMPA, FL, Feb. 25, 2019 -- February 25, 2019 – Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated drug.
TAMPA, FL, Feb. 07, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated healthcare platform, announced today its participation in the Healthcare.